| |
| |
|
| Insider
Information: |
Schleifer Leonard S |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
466,877 |
|
|
Indirect Shares
|
228,469 |
|
|
| Direct
Value |
$468,254,287 |
|
|
|
Indirect Value
|
$229,142,984 |
|
|
| Total
Shares |
695,346 |
|
|
| Total
Value |
$697,397,271 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-17 |
466,877 |
2024-05-17 |
228,469 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2013-09-18 |
4 |
D |
$304.38 |
$35,137,627 |
D/D |
(115,440) |
145,036 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2016-12-15 |
4 |
D |
$380.09 |
$51,463,046 |
D/D |
(135,397) |
157,409 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2017-12-13 |
4 |
D |
$385.08 |
$52,300,025 |
D/D |
(135,816) |
271,593 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2014-10-27 |
4 |
D |
$402.69 |
$55,742,766 |
D/D |
(138,426) |
160,469 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2018-12-13 |
4 |
D |
$377.31 |
$60,419,028 |
D/D |
(160,131) |
423,962 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2019-12-12 |
4 |
D |
$377.16 |
$61,085,965 |
D/D |
(161,963) |
474,499 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-13 |
4 |
OE |
$399.66 |
$81,212,511 |
D/D |
203,204 |
577,633 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2020-05-12 |
4 |
AS |
$557.51 |
$85,908,042 |
D/D |
(150,922) |
474,499 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2020-05-11 |
4 |
D |
$571.43 |
$92,330,517 |
D/D |
(161,578) |
625,421 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-11-19 |
4 |
OE |
$179.13 |
$115,030,120 |
D/D |
520,313 |
651,568 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-18 |
4 |
AS |
$650.03 |
$130,006,000 |
D/D |
(200,000) |
304,746 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-08-06 |
4 |
D |
$607.51 |
$138,861,598 |
D/D |
(228,575) |
504,746 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Bd. Co-Chair, President & CEO |
• • – |
2024-05-13 |
4 |
D |
$976.79 |
$141,080,710 |
D/D |
(144,433) |
433,200 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CEO |
• • – |
2021-11-19 |
4 |
D |
$651.96 |
$234,142,959 |
D/D |
(359,137) |
465,922 |
0 |
- |
|
89 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
